Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12234-12248
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12234
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12234
Figure 1 Extension of overall survival and development of chemotherapy regimens in metastatic colorectal cancer.
5-FU: 5-fluorouracil; LV: Leucovorin; FOLFIRI: Irinotecan, bolus 5-FU/LV and infusional 5-FU; FOLFOX: Oxaliplatin, bolus 5-FU/LV and infusional 5-FU; FOLFOXIRI: Irinotecan, oxaliplatin, bolus 5-FU/LV and infusional 5-FU.
- Citation: Fujita KI, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 2015; 21(43): 12234-12248
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12234